TY - JOUR
T1 - Association Between Accumulation of Advanced Glycation End-Products and Hearing Impairment in Community-Dwelling Older People
T2 - A Cross-Sectional Sukagawa Study
AU - The Sukagawa Study Group
AU - Niihata, Kakuya
AU - Takahashi, Sei
AU - Kurita, Noriaki
AU - Yajima, Nobuyuki
AU - Omae, Kenji
AU - Fukuma, Shingo
AU - Okano, Takayuki
AU - Nomoto, Yukio
AU - Omori, Koichi
AU - Fukuhara, Shunichi
AU - Hasegawa, Takeshi
AU - Iida, Hidekazu
AU - Kobayashi, Susumu
AU - Sasaki, Sho
AU - Naganuma, Toru
AU - Nishiwaki, Hiroki
AU - Tominaga, Ryoji
N1 - Publisher Copyright:
© 2017 AMDA – The Society for Post-Acute and Long-Term Care Medicine
PY - 2018/3
Y1 - 2018/3
N2 - Objectives: The experimental studies suggested the hypothesis that the accumulation of advanced glycation end-products (AGEs) could induce hearing impairment. The purpose of this study is to examine the hypothesis among elderly people using an epidemiologic approach. Design: Cross-sectional study. Setting: Sukagawa City, Fukushima, Japan. Participants: A total of 270 residents aged 75 years or over without dementia, who participated in a health check-up conducted in 2015. Measurements: The exposure variable was AGEs, which was assessed using skin autofluorescence (AF) as a proxy measure. The primary outcome was moderate hearing impairment or worse, which was defined as a pure tone average of thresholds ≥41 decibel hearing level at 0.5, 1, 2, and 4 kHz in the better-hearing ear. The secondary outcome was the pure tone average of thresholds as a continuous variable. We estimated the odds ratio using a logistic regression model for the primary outcome and a general linear model for the mean difference in the pure tone average of thresholds for the secondary outcome. Both models were adjusted for relevant confounding factors: age, sex, smoking, diabetes, hypertension, and history of cerebrovascular diseases. Results: The median (interquartile range) AF was 2.2 (2.0, 2.5) arbitrary units (AU). Moderate hearing impairment was reported in 88 participants (32.6%). For the primary outcome, we found significant associations between moderate hearing impairment and AF (adjusted odds ratio per 1 AU, 2.60; 95% confidence interval 1.26–5.35). For the secondary outcome, we also found a significant association between a 1-AU increase in AF and increased pure tone average, with a difference (6.52 dB per 1 AU; 95% confidence interval 2.18–10.86) comparable in magnitude to the increase in pure tone average observed for a 6-year increase in age in our population. Conclusions: Our study indicated that high levels of AGEs were independently associated with hearing impairment. Modifying levels of AGEs may prevent hearing impairment.
AB - Objectives: The experimental studies suggested the hypothesis that the accumulation of advanced glycation end-products (AGEs) could induce hearing impairment. The purpose of this study is to examine the hypothesis among elderly people using an epidemiologic approach. Design: Cross-sectional study. Setting: Sukagawa City, Fukushima, Japan. Participants: A total of 270 residents aged 75 years or over without dementia, who participated in a health check-up conducted in 2015. Measurements: The exposure variable was AGEs, which was assessed using skin autofluorescence (AF) as a proxy measure. The primary outcome was moderate hearing impairment or worse, which was defined as a pure tone average of thresholds ≥41 decibel hearing level at 0.5, 1, 2, and 4 kHz in the better-hearing ear. The secondary outcome was the pure tone average of thresholds as a continuous variable. We estimated the odds ratio using a logistic regression model for the primary outcome and a general linear model for the mean difference in the pure tone average of thresholds for the secondary outcome. Both models were adjusted for relevant confounding factors: age, sex, smoking, diabetes, hypertension, and history of cerebrovascular diseases. Results: The median (interquartile range) AF was 2.2 (2.0, 2.5) arbitrary units (AU). Moderate hearing impairment was reported in 88 participants (32.6%). For the primary outcome, we found significant associations between moderate hearing impairment and AF (adjusted odds ratio per 1 AU, 2.60; 95% confidence interval 1.26–5.35). For the secondary outcome, we also found a significant association between a 1-AU increase in AF and increased pure tone average, with a difference (6.52 dB per 1 AU; 95% confidence interval 2.18–10.86) comparable in magnitude to the increase in pure tone average observed for a 6-year increase in age in our population. Conclusions: Our study indicated that high levels of AGEs were independently associated with hearing impairment. Modifying levels of AGEs may prevent hearing impairment.
KW - Advanced glycation end-products
KW - elderly
KW - hearing impairment
UR - http://www.scopus.com/inward/record.url?scp=85032230666&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85032230666&partnerID=8YFLogxK
U2 - 10.1016/j.jamda.2017.09.008
DO - 10.1016/j.jamda.2017.09.008
M3 - Article
C2 - 29079032
AN - SCOPUS:85032230666
SN - 1525-8610
VL - 19
SP - 235-239.e1
JO - Journal of the American Medical Directors Association
JF - Journal of the American Medical Directors Association
IS - 3
ER -